Kazia Therapeutics Quote - NV9 | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Germany
TG
Kazia Therapeutics Limited (NV9) Share Price

Kazia Therapeutics Limited (NV9)

0.00

0.00

(0.00%)

Closed 14 March 8:00AM

Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

-

Bid

-

Offer

-

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

-

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

0.00

Shares Outstanding

204,338,069

Dividend Yield

-

PE Ratio

0.00

Earnings Per Share (EPS)

-

Revenue

2.31M

Net Profit

-27.32M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kaziatherapeutics.com

Headquarters

Sydney, New South Wales, Aus

Founded

-

Kazia Therapeutics Limited is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NV9. The last closing price for Kazia Therapeutics was -. Over the last year, Kazia Therapeutics shares have traded in a share price range of 0.00 € to 0.00 €.

Kazia Therapeutics currently has 204,338,069 shares in issue.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0.0965	0.0965	0.03	73175	0.04009102	DE
260	0	0	0.0965	0.0965	0.03	73175	0.04009102	DE

NV9 - Frequently Asked Questions (FAQ)

What is the current Kazia Therapeutics share price?

The current share price of Kazia Therapeutics is 0.00 €

How many Kazia Therapeutics shares are in issue?

Kazia Therapeutics has 204,338,069 shares in issue

What is the 1 year trading range for Kazia Therapeutics share price?

Kazia Therapeutics has traded in the range of 0.00 € to 0.00 € during the past year

What is the reporting currency for Kazia Therapeutics?

Kazia Therapeutics reports financial results in AUD

What is the latest annual turnover for Kazia Therapeutics?

The latest annual turnover of Kazia Therapeutics is AUD 2.31M

What is the latest annual profit for Kazia Therapeutics?

The latest annual profit of Kazia Therapeutics is AUD -27.32M

What is the registered address of Kazia Therapeutics?

The registered address for Kazia Therapeutics is THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO TOWERS, SYDNEY, NEW SOUTH WALES, 2000

What is the Kazia Therapeutics website address?

The website address for Kazia Therapeutics is www.kaziatherapeutics.com

Which industry sector does Kazia Therapeutics operate in?

Kazia Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
E3O1Nexoptic Technology Corp	0.013 € (52.94%)	7.63k
VOPInvestigator Resources Ltd	0.0175 € (40.00%)	4.89k
IAHInternational Lithium Corp	0.0145 € (38.10%)	20.1k
K6SMira Pharmaceuticals Inc	1.20 € (37.93%)	3.67k
B5S0NU E Power Corp	0.283 € (36.06%)	76.19k
9COCorus Entertainment	0.0335 € (-43.70%)	460
C0MCCS Abwicklungs AG	0.08 € (-42.45%)	196.61k
47GAGo Metals Corp	0.0142 € (-36.61%)	4.13k
M0YNMynaric AG	0.866 € (-35.85%)	429.67k
WIG1Wige Media AG	0.017 € (-35.85%)	1.44M
D7GNel ASA	0.28 € (-11.81%)	36.74M
RQ0DWave Quantum Inc	6.384 € (19.95%)	3.19M
DRHDroneShield Limited	0.575 € (7.68%)	2.21M
DMLSayona Mining Limited	0.0115 € (-4.96%)	1.88M
WIG1Wige Media AG	0.017 € (-35.85%)	1.44M

BDEZ

BDEZ 5 minutes ago

https://x.com/teux01/status/1900377824596283833

boston127

boston127 5 minutes ago

They have not stolen my money.

My investment is down 99%, but they did not steal it.

CanItBThisEZ2Make

CanItBThisEZ2Make 5 minutes ago

$MAXN
Buy: 47,739
Neutral: 71,756
Sell: 110,174
Volume: 229,669

DiscoverGold

DiscoverGold 6 minutes ago

Orange Juice has now plummeted more than 50% over the last 3 months. Bottomless Mimosas are now back, congrats everyone
By: Barchart | March 13, 2025

• Orange Juice

OJ has now plummeted more than 50% over the last 3 months Bottomless Mimosas are now back, co

littlejohn

littlejohn 8 minutes ago

Future view, 66 to 67 for SMCI is key

area to top as video details...

https://youtu.be/EYNqS7SSNbw

T A in video is presented better than my

peon rambling about it...

Kinda like Charles of SMCI dodging questions

MetaMonster

MetaMonster 8 minutes ago

It's all a scam, a hoax, smoking mirrors at it's best, trump will put all these short motherfuckers in jail for fraud, theft, mass murder,rape at all levels of foul play to all shareholders Founders and Management must be jailed immediately with no bail

Lax76

Lax76 10 minutes ago

That's new. The site is growing!!

surfer44

surfer44 10 minutes ago

Excellent discussion of the U.S budget, deficits, and debt. In short, it's unsustainable.

Live with Rick Rule and David Stockman

https://youtu.be/eu2Ib70ohiE

downdraft

downdraft 11 minutes ago

I only recently jumped in when I learned that BIXT had entered into a Joint Venture agreement with the Heme Foundation back on July 15, 2024. That's just huge.

The Heme Foundation has already allocated $10 million towards the development of BIXT's Universal Oxygen Carrier (UOC). F

arizona1

arizona1 11 minutes ago

He was found guilty in a court of law by a jury of his peers just like you were.

NY1972

NY1972 14 minutes ago

SLE and CART
https://pmc.ncbi.nlm.nih.gov/articles/PMC11694027/#B181

MetaMonster

MetaMonster 15 minutes ago

Fitzgerald is going to jail for fraud, the word is out on the streets ,he has been declared the fraud artist on wall street

gfp927z

gfp927z 15 minutes ago

Silver_bars, >> pork money

boi568

boi568 15 minutes ago

This appears to be an international patent application, and not a granted patent.

I have not read much more than the first page, but I did notice Figure 1, which a graphical form of the illustration Anavex has been displaying of the parts of the brain that are more or less impacted by

Howeeme

Howeeme 17 minutes ago

Mr. DeFilippis most recently served as the Senior Vice President, CBO of Halozyme, where he was responsible for business development, alliance management and project management. Prior to Halozyme, he was the Senior Vice President, Device Business and Alliances at Antares Pharma managing combination

rooster

rooster 19 minutes ago

Pretend fantasy charges don’t count

Think1st

Think1st 20 minutes ago

What positive did you hear and how does it differentiate from other positives we heard

ap17

ap17 21 minutes ago

.08 CENTS!! my apologies for missing it by 2 cents. My call was .10 2+ years ago. Told ya, never marry a stock especially a POS like this.

theswordman

theswordman 21 minutes ago

The company that has kytruda could be a good partner option

"Merck has the industry’s largest immuno-oncology clinical research program. There are currently more than 1,200 trials studying KEYTRUDA across a wide variety of cancers and treatment settings."

https://www.

moola26

moola26 21 minutes ago

Amazing stuff!! We are GOLDEN!!
MAJORITY HOLDING STRONG$$$$

jimr1717

jimr1717 21 minutes ago

Paullee

Paullee 22 minutes ago

Audio file
LWLG inv call 3_13_25
Transcript
00:00:01 Speaker 1
Thank you, Ryan, and thank you to those who have joined this call. Since our last call on January 9th, we have received questions looking for clarity on some of the initiatives we discussed that day.
0

D-man4

D-man4 22 minutes ago

From what I'm hearing they don't want to do a buyback until there is more volume, but wouldn't buying back shares increase the volume in and of itself when folks realized the buyback had commenced and FOMO kicks in? Would it not create a snowball effect of more and more volume which would allow them

Kazia Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions